These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7394864)

  • 1. Effects of gamma-hydroxybutrate and gamma-butyrolactone on cerebral energy metabolism during exposure and recovery from hypoxemia-oligemia.
    MacMillan V
    Stroke; 1980; 11(3):271-7. PubMed ID: 7394864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effects of gamma-hydroxybutyrate and gamma-butyrolactone on cerebral carbohydrate metabolism.
    MacMillan V
    Can J Physiol Pharmacol; 1979 Aug; 57(8):787-97. PubMed ID: 40677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of gamma-hydroxybutyrate and gamma-butyrolactone upon the energy metabolism of the normoxic and hypoxic rat brain.
    MacMillan V
    Brain Res; 1978 May; 146(1):177-87. PubMed ID: 25695
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebral energy metabolism during recovery from carbon monoxide hypoxia-oligemia.
    MacMillan V
    Brain Res; 1978 Aug; 151(2):353-68. PubMed ID: 679014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone.
    Lettieri J; Fung HL
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):107-18. PubMed ID: 725311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of promethazine on the energy metabolism of normoxic and hypoxic rat brain.
    MacMillan V
    Stroke; 1982; 13(4):464-9. PubMed ID: 7101346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gamma-Hydroxybutyrate: cerebral metabolic, vascular, and protective effects.
    Artru AA; Steen PA; Michenfelder JD
    J Neurochem; 1980 Nov; 35(5):1114-9. PubMed ID: 7452308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion.
    Sadasivan S; Maher TJ; Quang LS
    Ann N Y Acad Sci; 2006 Aug; 1074():537-44. PubMed ID: 17105951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma butyrolactone (GBL) and gamma valerolactone (GVL): similarities and differences in their effects on the acoustic startle reflex and the conditioned enhancement of startle in the rat.
    Marinetti LJ; Leavell BJ; Jones CM; Hepler BR; Isenschmid DS; Commissaris RL
    Pharmacol Biochem Behav; 2012 Jun; 101(4):602-8. PubMed ID: 22349589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral monoamine and energy metabolism during recovery from hypoxia-oligemia.
    MacMillan V
    Can J Physiol Pharmacol; 1980 Feb; 58(2):147-52. PubMed ID: 7378916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges.
    Snead OC
    Neuropharmacology; 1991 Feb; 30(2):161-7. PubMed ID: 2030821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of
    Follman KE; Morris ME
    J Pharmacol Exp Ther; 2019 Jul; 370(1):84-91. PubMed ID: 31010842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gamma-hydroxybutyrate and gamma-butyrolactone derivates on spontaneous generalized non-convulsive seizures in the rat.
    Depaulis A; Bourguignon JJ; Marescaux C; Vergnes M; Schmitt M; Micheletti G; Warter JM
    Neuropharmacology; 1988 Jul; 27(7):683-9. PubMed ID: 3419549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats.
    Baker LE; Van Tilburg TJ; Brandt AE; Poling A
    Psychopharmacology (Berl); 2005 Sep; 181(3):458-66. PubMed ID: 16001124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in alcoholic and non-alcoholic beverages.
    Elliott S; Burgess V
    Forensic Sci Int; 2005 Jul; 151(2-3):289-92. PubMed ID: 15939164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone prevents hypoxia/ischemia-induced reductions in cerebral glucose utilization and high-energy phosphate metabolites in immature brain.
    Tuor UI; Yager JY; Bascaramurty S; Del Bigio MR
    J Neurochem; 1997 Nov; 69(5):1954-63. PubMed ID: 9349540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone.
    Lenz D; Rothschild MA; Kröner L
    Ther Drug Monit; 2008 Dec; 30(6):755-61. PubMed ID: 18824955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of combined hypocapnia and hypoxemia upon the energy metabolism of the brain.
    MacMillan V
    Can J Physiol Pharmacol; 1974 Dec; 52(6):1136-46. PubMed ID: 4451885
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone.
    Morse BL; Morris ME
    J Pharmacol Exp Ther; 2013 Apr; 345(1):102-10. PubMed ID: 23392755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral glucose and energy utilization during the evolution of hypoxic-ischemic brain damage in the immature rat.
    Vannucci RC; Yager JY; Vannucci SJ
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):279-88. PubMed ID: 8113323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.